Drug Database
EP

epinephrine (epinephrine, Dey / EpiPen / epinephrine, Mylan)

✓ Approved

Mylan · 小分子 · 小分子

什么是 epinephrine?

epinephrine 是一种小分子,由Mylan研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

商品名epinephrine, Dey, EpiPen, epinephrine, Mylan
公司Mylan
药物类别小分子
给药途径Injectable (Others)
状态Approved

治疗适应症

epinephrine 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Immune system disordersAnaphylactic reaction✓ Approved

相关研究文献

PubMedJournal of cardiothoracic and vascular anesthesia2026-11-16

Milrinone versus Epinephrine in Cardiac Surgery: An Entropy-Balanced Cohort Study.

Peiris Sashi S, Peiris Thanushi T, Sin Jesselyn J, Karamesinis Alexandra A et al.

To compare clinical outcomes associated with milrinone and epinephrine use after cardiac surgery. Single-center, retrospective, entropy-balanced cohort study. Intensive care unit (ICU) of a large tertiary academic hospital in the United States, 2001-2022. Adult patients admitted to intensive care after cardiac surgery. Initial treatment with milrinone or epinephrine within 48 hours of ICU admission, classified by the agent started first. The primary outcome was 90-day mortality. Secondary outcomes included acute kidney injury, renal replacement therapy, ICU length of stay (LOS), hospital LOS, and time in postoperative organ dysfunction. Of 13,023 cardiac surgical patients, 1,310 (10%) received milrinone (312 [24%]) or epinephrine (998 [76%]) as the first agent. After entropy balancing, there was no evidence of a difference in 90-day mortality between milrinone and epinephrine groups (7.1% v 6.6%; risk ratio [RR], 1.1; 95% CI, 0.67-1.7). Milrinone was associated with longer ICU LOS (mean difference [MD], +1.8 days; 95% CI, 0.74-3.0), longer hospital LOS (MD, +1.2 days; 95% CI, 0.11-2.3), longer time in postoperative organ dysfunction (MD, +14 hours; 95% CI, 7.5-21), higher risk of acute kidney injury (73% v 61%; RR, 1.2; 95% CI, 1.1-1.3), and higher risk of renal replacement therapy (13% v 7.6%; RR, 1.7; 95% CI, 1.2-2.3). In this entropy-balanced study, there was no evidence of a difference in 90-day mortality between milrinone and epinephrine. Milrinone was associated with more complications and longer LOS, though these findings remain hypothesis-generating and warrant a randomized trial.

PMID 43039778
阅读全文 →
PubMedJournal of cataract and refractive surgery2026-11-16

Effect of Preoperative Topical 0.1% Nepafenac in Patients Undergoing Phacoemulsification With Pseudoexfoliation Syndrome or Mature Cataract.

Alyörük Furkan F, Bektas Caglar C, Gungor Buket B, Turgut Burak B

To evaluate the effect of preoperative topical 0.1% nepafenac on intraoperative pain, pupil dynamics, and surgical outcomes in eyes with pseudoexfoliation syndrome (PEX) or mature cataract undergoing phacoemulsification. Department of Ophthalmology, Çanakkale Onsekiz Mart University Hospital, Çanakkale, Türkiye. Prospective, non-randomized comparative clinical study. Patients with PEX or mature cataract undergoing phacoemulsification received preoperative topical 0.1% nepafenac or no nepafenac. Pupil diameters were measured from surgical videos at surgery start (T1), after intracameral epinephrine (T2), after nucleus removal (T3), after cortex aspiration (T4), and after intraocular lens implantation (T5). Intraoperative pain, complications, and surgical outcomes were assessed. A total of 126 eyes were included: 32 PEX without nepafenac, 33 PEX with nepafenac, 31 mature cataract without nepafenac, and 30 mature cataract with nepafenac. Baseline characteristics were comparable among the groups (all P > .05). In PEX eyes, nepafenac did not significantly affect pupil diameter at any time point. In mature cataract eyes, pupil diameters were similar through T3 but significantly larger with nepafenac at T4 (7.30 ± 1.05 vs 6.38 ± 1.29 mm; P = .004) and T5 (6.85 ± 1.14 vs 5.87 ± 1.29 mm; P = .003). Pain scores, complication rates, and surgical outcomes were comparable between groups. Preoperative nepafenac improved maintenance of mydriasis during later surgical stages in mature cataract eyes but showed no significant benefit in PEX eyes. No significant effect on intraoperative pain or surgical outcomes was observed.

PMID 43037593
阅读全文 →
PubMedAnaesthesia and intensive care2026-11-16

A sympathetic solution: Brachial plexus blockade for suspected adrenaline-induced vasospasm.

Nelson Luke L

Vasospasm threatens perfusion across recently reconstructed vessels. Systemic adrenaline, (epinephrine) the first-line treatment for anaphylaxis, is a potent vasoconstrictor, and therefore represents a potential, albeit necessary, threat to newly reconstructed vessels. Brachial plexus blockade may dampen localised vasoconstriction, allowing for improved vascular perfusion and reduced risk of vasospasm. An adult male sustained a workplace injury resulting in an open fracture-dislocation of the distal radius and fracture and accompanying radial and ulnar artery transections, requiring a vein graft repair to both vessels and external fixation of the radius and ulna. At 36 h post-operatively, the patient developed anaphylaxis to intravenous amoxicillin-clavulanic acid, requiring boluses and subsequent infusion of adrenaline for anaphylaxis management. Within minutes, the affected limb distal to the arterial repair became pale, cold, pulseless and painful. Adrenaline-induced vasospasm was presumed after multidisciplinary discussion. An ultrasound-guided supraclavicular brachial plexus block using 20 ml of 0.5% ropivacaine was performed as a salvage measure while surgical re-exploration was being considered. Perfusion and pain improved within minutes and had a sustained effect in the setting of adrenaline infusion. The infusion was ceased after 8 h, and the block resolved after approximately 12 h without recurrence of vasospasm. Re-exploration was not required, given the clinical suspicion and subsequent improvement post-block. Brachial plexus block performed for presumed adrenaline-induced vasospasm restored vascular perfusion, by presumed selective blockade of sympathetic ganglion that is responsible for local vasoconstriction, while not counteracting the systemic effects of IV adrenaline administration.

PMID 43036878
阅读全文 →
PubMedJournal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons2026-11-15

Effect of Pre-Extubation Bupivacaine Infiltration on Postoperative Pain and Opioid Consumption After Orthognathic Surgery.

Beyler Esra E, Altıparmak Nur N, Kesen Merve Berrak MB, Akdeniz Sıdıka Sinem SS

Effective postoperative pain control with reduced opioid use is a key goal in orthognathic surgery. To compare postoperative pain and morphine consumption between subjects with and without additional pre-extubation bupivacaine infiltration following bimaxillary orthognathic surgery. Patients undergoing bimaxillary orthognathic surgery at Başkent University Faculty of Dentistry, Ankara, Türkiye, between 2022 and 2025 were assessed for eligibility for this randomized controlled trial. Exclusion criteria were refusal to participate, American Society of Anesthesiologists score ≥ III, congenital craniofacial anomalies, chronic opioid use, allergy to local anesthetics or opioids, and previous maxillofacial surgery. The predictor variable was therapy, and subjects were randomly assigned to additional pre-extubation infiltration with 0.5% bupivacaine/epinephrine (1:200,000) or no additional infiltration. The primary outcome was visual analog scale pain score at 3, 6, 9, 12, 18, 24, 30, and 48 hours. The secondary outcomes were 24-hour total and rescue morphine consumption (additional morphine for breakthrough pain). Age, sex, anesthesia duration, and hospital length of stay. Categorical variables were analyzed using the χ2 test, continuous variables using the Mann-Whitney U test, and repeated measurements using a linear mixed-effects model. Statistical significance was set at P < .05. A total of 108 patients were assessed, and the final sample comprised 102 (94.4%) subjects who were randomized (51 per group). The mean age was 23.6 (5.4) years; 50 (49.0%) were female and 52 (51.0%) were male. The mean (SD) visual analog scale scores in the study/control groups were as follows: 3 h, 0.33 (0.25)/1.32 (0.32); 6 h, 1.23 (0.32)/2.13 (0.43); 9 h, 2.13 (0.30)/3.01 (0.40); 12 h, 3.00 (0.28)/3.90 (0.33); 18 h, 3.26 (0.32)/4.30 (0.37); 24 h, 3.18 (0.33)/4.02 (0.41); 30 h, 3.46 (0.26)/4.37 (0.35); and 48 h, 2.14 (0.28)/3.16 (0.36) (all P < .001). Rescue morphine consumption was 2.27 (1.25) mg versus 4.31 (1.05) mg, and total morphine consumption was 9.47 (1.25) mg versus 11.51 (1.05) mg in the study and control groups, respectively (both P < .001). Additional pre-extubation bupivacaine infiltration statistically significantly reduced postoperative pain and morphine consumption following bimaxillary orthognathic surgery and may present a simple adjunct to multimodal analgesia.

PMID 43033828
阅读全文 →
PubMedAnimal reproduction science2026-11-14

Effect of pentoxifylline and of penicillamine, hypotaurine and epinephrine on motility of poor-motility frozen-thawed semen in stallions.

Sandoval-Rosales Leslie L, Felix Matheus M, Santos Rebeca R, Martinez de Andino Elena V EV et al.

Intracytoplasmic sperm injection (ICSI) allows equine embryo production from low-quality semen. However, some frozen-thawed semen has such low motility that selection of motile sperm for injection is challenging. To explore methods to increase sperm motility to facilitate selection during ICSI, we evaluated the effects of pentoxifylline and of penicillamine, hypotaurine and epinephrine (PHE) on both standard frozen-thawed (1x) semen and a model of poor-motility semen (4x, frozen and thawed four times). In Exp. 1, 1x and 4x semen was treated with 0.5, 1, 2 or 4 mg/mL pentoxifylline; in Exp. 2, 1x and 4x semen was treated with 2 or 4 mg/mL pentoxifylline, or with low or high concentrations of PHE (18 µM penicillamine, 9 µM hypotaurine and 1.8 µM epinephrine, or twice this concentration). Semen from three stallions was used for each experiment. Total (TMOT) and progressive (PMOT) motility were assessed by computer-assisted sperm analysis, and data analyzed using the Friedman test with pairwise Wilcoxon tests. In Exp. 1, pentoxifylline had no significant effect on motility of 1x semen, but increased TMOT and PMOT of 4x semen in a dose-dependent manner (P < 0.05). In Exp. 2, pentoxifylline significantly increased PMOT at 0 and 30 min for 1x semen, and TMOT and PMOT up to two hours in 4x semen. In an exploratory trial, ICSI with pentoxifylline-treated sperm yielded a 37% blastocyst rate (4/11), vs. 30% (3/10) for control sperm. We conclude that PTX, but not PHE, may have application to increase motility during selection of sperm for ICSI.

PMID 43025359
阅读全文 →
PubMedThe American journal of emergency medicine2026-11-14

Pediatric cardiopulmonary resuscitation in the emergency department: Factors associated with outcome.

Baran Özge Ö, Eser Öznur Ö, Er Anıl A, Arayıcı Mehmet Emin ME et al.

Pediatric cardiac arrest is usually studied either before hospital arrival or after admission, although the emergency department (ED) team resuscitates both. We examined factors associated with return of spontaneous circulation (ROSC), recurrent arrest and mortality in an ED cohort including both out-of-hospital cardiac arrests (OHCA) and in-ED cardiac arrests. Retrospective cohort of all 83 children who received cardiopulmonary resuscitation (CPR) in a university pediatric ED over 14 years (January 2010-March 2024). The primary outcome was survival to hospital discharge; multivariable logistic regression identified factors independently associated with ED mortality. Median age was 35 months; 54.2% occurred out of hospital. ROSC was achieved in 42.2% and 30.1% survived the ED phase, but 9.9% survived to discharge. Epinephrine given later than 2 min was independently associated with ED mortality among the 27 patients with documented timing (adjusted odds ratio [aOR] 7.73; 95% confidence interval [CI] 1.27-46.97). Beyond 20 min of CPR, each additional minute was associated with ED death (aOR 1.32; 95% CI 1.01-1.73). Recurrent arrest after ROSC in the ED occurred in 42.9%, of whom 6.7% survived versus 38.9% without recurrence (p = 0.039). Survival did not differ by arrest location, initial rhythm or timing of advanced airway management. Resuscitation in the ED restored spontaneous circulation in many children, but few survived to discharge. Time to first epinephrine was independently associated with ED mortality in this cohort, whereas prolonged resuscitation and recurrent arrest after ROSC in the ED identified children at very high risk.

PMID 43025004
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多epinephrine